Cavernous sinus thrombosis

Patients should be monitored by family for signs of neurological deterioration, infection (e.g., fever), and change in mental status. Patients taking anticoagulation should receive training on prevention of falls, monitoring of relevant coagulation parameters, and interactions with other blood-thinning agents. Withdrawal of anticoagulation can be considered at a deferred time frame, typically several weeks to months. This will depend on the resolution of both the clinical symptoms and imaging. Close, multi-disciplinary follow-up is required with neurology, neurosurgery, infectious disease, endocrinology, and haematology specialists.